Dr. Darren Schulte is the CEO of Apixio where they are using data to move medicine from a practice to a science. Improving healthcare outcomes requires access to the right data at the right time. Apixio is advancing value-based care with data-driven intelligence and analytics.

I wanted to learn more about how their AI solutions for risk, quality, and clinical insights unlock actionable information from administrative data and unstructured clinical information. The results drive better clinical decision-making and a smarter approach to healthcare. We also discuss how COVID-19 has impacted healthcare.

About Dr. Darren Schulte

Before joining Apixio, Darren served in executive leadership roles at Alere Health, Anvita Health, and Resolution Health. Darren co-developed twenty-five clinical measures endorsed by the National Quality Forum to measure ambulatory care quality using electronic data. He is a nationally recognized speaker on the topics of healthcare analytics and quality improvement.

Darren received his B.S. degree from U.C. Berkeley, his M.P.P. degree from Harvard, his M.D. from Stanford, and trained in Internal Medicine at University of California, San Francisco. Darren serves as a Board of Trustee at the Chinese American International School in San Francisco. He is the co-author of two US patents.